CDC gives full approval to RSV vaccine for people over 60
Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention has announced.
Jul 3, 2023
0
47
Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention has announced.
Jul 3, 2023
0
47
COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.
Jun 15, 2023
0
20
A newly defined risk threshold may inform decision-making for the appropriateness of rabies postexposure prophylaxis, according to a study published online June 9 in JAMA Network Open.
Jun 13, 2023
0
3
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
Jun 9, 2023
0
2
The US drug regulator approved a second vaccine against respiratory syncytial virus (RSV), its American developer Pfizer said Wednesday, a month after the authorization of the first shot against the pathogen, a leading cause ...
Jun 1, 2023
0
2
U.S. health officials are bracing for the possibility that mpox could surge again this summer as cases mount in several states.
May 26, 2023
0
2
An estimated 2.8 million people around the world have multiple sclerosis (MS), an autoimmune disease in which the immune system damages the brain and spinal cord.
May 22, 2023
0
6
The first RSV vaccine designed to protect infants is under consideration by a panel of advisers to the U.S. Food and Drug Administration.
May 18, 2023
0
2
For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
U.S. deaths fell last year, and COVID-19 dropped to the nation's No. 4 cause, the Centers for Disease Control and Prevention reported Thursday.
May 4, 2023
0
2